United States · FDA National Drug Code directory
BRYNOVIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 24338-017_9468a2f3-3ebe-40bd-a3b4-d78d9eb47e04
- Product NDC
- 24338-017
- Form
- SOLUTION
- Composition / generic term
- Sitagliptin Hydrochloride Oral
- Labeler
- Azurity Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20250401
- Source listing expiry
- 20261231
Source-listed ingredients
- SITAGLIPTIN — 25 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (24338-017-01) / 120 mL in 1 BOTTLE · 24338-017-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →